Day: September 26, 2024

Cutting-Edge Gear to Empower Athletes in the Ultimate Endurance ChallengeStrategic Alliance Unites Innovation and Performance for Unprecedented Racing Success SANTA BARBARA, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) — DRYWORLD Brands Inc. (OTC: IBGR), a leading performance athletic brand, is excited to announce a ground-breaking partnership with Spartan Race, the global leader in extreme participation sports. The strategic alliance sees DRYWORLD become the exclusive and official compression partner of Spartan World Championships being held in Croatia and Greece in October and November respectively – it marks a significant milestone in both companies’ commitment to pushing the boundaries of athletic performance and innovation. Spartan Race, the global leader in extreme participation sports, is a series of obstacle races of varying...

PARIS, Sept. 26, 2024 (GLOBE NEWSWIRE) — Constellium is pleased to announce a partnership with Tesem, a global leader in luxury packaging, to advance sustainable aluminium production through an initiative called “Closing the Loop.” This collaboration underscores Constellium’s dedication to reducing environmental impact and promoting circular economy practices. Through this partnership, Constellium will work closely with Tesem to create a closed-loop system that enables the recycling of high-purity aluminium. Tesem has invested in enhancing their assets to ensure the efficient cleaning and preparation of aluminium scrap. Both companies’ R&D teams have collaborated to ensure the scrap meets the stringent quality standards required and to adjust casting parameters to integrate higher levels of recycled material. This...

NORWOOD, Mass., Sept. 26, 2024 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that the Company will participate in BMO Capital Markets’ Oncology Summit, to be held October 8, 2024 in New York, NY. Dr. Dominic Smethurst, MA MRCP, Chief Medical Officer of Corbus, will participate in a panel titled Capitalizing on Validated Mechanism in Oncology. Dr. Smethurst will also be joined by Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, to participate in one-on-one investor meetings. Panel Title: Capitalizing on Validated Mechanism in OncologyDate: Tuesday, October 8, 2024Presentation Time: 1:30 pm ET Please contact your BMO Capital Markets sales representative to register for the conference. About CorbusCorbus Pharmaceuticals Holdings, Inc. is an oncology company...

Designed to Accelerate it Insurance Business Boca Raton, FL, Sept. 26, 2024 (GLOBE NEWSWIRE) — Janover Inc. (Nasdaq:  JNVR) (“Janover” or the “Company”), an AI-enabled platform for commercial real estate transactions, today announced the launch of new AI tools to accelerate business development activities within its Insurtech subsidiary, Janover Insurance Group. The new tools include autonomous agents designed to reach out to as well as re-engage the Company’s extensive user database, which includes more than 100,000 contacts. The newly introduced features include advanced email and SMS capabilities, boosting the sales team’s effectiveness, while delivering a more streamlined, efficient experience for customers. The Company also plans to introduce a significantly more capable outbound AI application in Q4 2024 to actively...

VANCOUVER, British Columbia and LONDON, Sept. 26, 2024 (GLOBE NEWSWIRE) — Key Carbon and Marex Group Plc (“Marex”) today announce a partnership whereby Marex will take a minority stake in Key Carbon and provide financing for carefully-sourced offset projects. Key Carbon sources and finances carbon credit projects and provides ongoing governance, monitoring and operational support to ensure its projects are held to the highest quality and integrity standards. The funding from Marex will predominantly be used to help finance the production and distribution of low-emission, affordable cookstoves within Africa through the project developer Global Cookstoves, Key Carbon’s joint venture with BURN Manufacturing (“BURN”). To date, Key Carbon has provided US$45 million in funding to Global Cookstoves to expand the roll out of critical projects...

New market research shows strong interest from ophthalmic surgeons following their review of Clobetasol’s prescribing information NEW YORK, Sept. 26, 2024 (GLOBE NEWSWIRE) — Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic technology company, today announced the U.S. launch and commercial availability of clobetasol propionate ophthalmic suspension 0.05% (“Clobetasol”), approved by the FDA for the treatment of post-operative inflammation and pain following ocular surgery. “The commercial launch of Clobetasol represents a significant milestone for our company, and as the first new ophthalmic steroid to be approved in more than 15 years, a meaningful advancement in the field of ocular surgery,” stated Michael Rowe, Chief Executive Officer of Eyenovia. “With its efficacy and safety profile, convenient twice-a-day dosing regimen, and streamlined...

NEW YORK, Sept. 26, 2024 (GLOBE NEWSWIRE) — Virtu Financial, Inc. (Nasdaq:VIRT), a leading provider of global, multi-asset financial services that delivers liquidity and innovative, transparent products across the complete investment cycle to the global markets, is proud to announce that Trish McMenamin, Chief Compliance Officer, and Leah Goldsberry, EMEA Head of Analytics Client Coverage, have both been recognized at Markets Media’s European Women in Finance Awards. Trish McMenamin received the Excellence in Legal and Compliance award for her leadership in transforming Virtu’s Dublin-based regulatory program and her collaboration efforts across the global platform and global teams. With over a decade of experience, Trish has consistently demonstrated integrity and a commitment to compliance excellence. Leah Goldsberry was awarded...

Company To Discuss Positive Results Presented at the International MDS Congress and the Design of Phase 1b Trial in Parkinson’s Disease Patients Event Will Be Held on Monday, September 30, 2024, at 8:30 am ET BETHESDA, Md., Sept. 26, 2024 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced it is holding a webinar to discuss data from the Phase 1 study of GT-02287, a novel GCase-targeting small molecule therapy for Parkinson’s disease, recently presented in a late-breaker at the International Congress of Parkinson’s Disease and Movement Disorders® (MDS). The Company will also discuss the design of a planned Phase 1b trial of GT-02287 in Parkinson’s...

LiiT Hard Iced Tea is Now Available Nationwide in 19.2-ounce Cans PORTLAND, Ore., Sept. 26, 2024 (GLOBE NEWSWIRE) — The Shock Top Company, a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), is excited to introduce its latest innovation: Shock Top LiiT Hard Iced Tea. With a robust 9% alcohol content by volume, this hard iced tea is designed to keep the good times rolling, even as the days get shorter. This isn’t your grandma’s iced tea. Shock Top’s LiiT packs a punch with bold flavors and a refreshing twist that’s perfect for those who aren’t quite ready to let go of summer. Think of it as your new go-to companion for all things fall – from tailgates to bonfires – LiiT is the beverage that’ll keep your spirits high as temperatures drop. Launching nationwide today, Shock Top LiiT Hard Iced Tea will be available in...